Matinas BioPharma Holdings MTNB
NYSE MTNB
$0.19 +0.01 (+3.66%)
As of: Aug 21, 2026 · 11:50 AM EDT

Matinas BioPharma Holdings (MTNB) EBT (2014 - 2026)

Matinas BioPharma Holdings (MTNB) posted quarterly EBT of -$1.9 million for Q1 2026, up 1.07% year-over-year from -$1.9 million in Q1 2025, and down 13.55% quarter-over-quarter from -$1.7 million in Q4 2025.

Matinas BioPharma Holdings (MTNB) EBT (2014 - 2026) Analysis & Trends

Matinas BioPharma Holdings (MTNB) has reported EBT for 13 consecutive years, with -$1.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, EBT rose 1.07% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at -$7.6 million (up 70.14% YoY), while the FY2025 annual figure was -$10.3 million, up 57.48% from the prior year.
  • EBT fell to -$1.9 million in Q1 2026 per MTNB's latest filing, from -$1.7 million in the prior quarter.
  • Across five years, EBT topped out at -$1.7 million in Q4 2025 and bottomed at -$39.9 million in Q4 2022.
  • Historically, EBT has averaged -$8.1 million across 5 years, with a median of -$6.8 million in 2024.
  • Annual changes were most pronounced in 2022 — EBT sank 107.67% — and 2023, when it jumped 85.23%.
  • Matinas BioPharma Holdings' EBT stood at -$39.9 million in 2022, then surged by 85.23% to -$5.9 million in 2023, then tumbled by 44.36% to -$8.5 million in 2024, then soared by 79.86% to -$1.7 million in 2025, then decreased by 13.55% to -$1.9 million in 2026.
  • Business Quant data shows MTNB's EBT at -$1.9 million in Q1 2026, -$1.7 million in Q4 2025, and -$1.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Vertex Pharmaceuticals 139.69 Bn 131.84 Bn 2.84 Bn 1.39 Bn
2 Regeneron Pharmaceuticals 86.46 Bn 78.47 Bn 3.93 Bn 1.53 Bn
3 Argenx Se 65.62 Bn 60.44 Bn 1.37 Bn 541.00 Mn
4 Moderna 58.37 Bn 53.24 Bn 52.00 Mn -767.00 Mn
5 BeOne Medicines 42.17 Bn 37.07 Bn 1.53 Bn 312.46 Mn
6 Alnylam Pharmaceuticals 31.73 Bn 28.43 Bn 992.69 Mn 177.81 Mn
7 BioNTech SE 28.27 Bn 9.87 Bn 668.28 Mn -264.70 Mn
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn -11.37 Mn
9 Royalty Pharma 27.23 Bn 26.40 Bn - 81.49 Mn
10 Matinas BioPharma Holdings 1.21 Mn 401,051.33 - -1.56 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.56 Mn
Mar 31, 2026 -1.94 Mn
Dec 31, 2025 -1.71 Mn
Sep 30, 2025 -1.85 Mn
Jun 30, 2025 -2.11 Mn
Mar 31, 2025 -1.97 Mn
Dec 31, 2024 -8.50 Mn
Sep 30, 2024 -5.33 Mn
Jun 30, 2024 -9.72 Mn
Mar 31, 2024 -6.85 Mn
Dec 31, 2023 -5.89 Mn
Sep 30, 2023 -7.17 Mn
Jun 30, 2023 -7.20 Mn
Mar 31, 2023 -6.66 Mn
Dec 31, 2022 -39.87 Mn
Sep 30, 2022 -10.95 Mn
Jun 30, 2022 -11.42 Mn
Mar 31, 2022 -8.48 Mn
Dec 31, 2021 -37.74 Mn
Sep 30, 2021 -13.02 Mn